Journal of the Formosan Medical Association
Volume 108, Issue 5 , Pages 402-408 , May 2009

Mutational Spectrum of Multiple Endocrine Neoplasia Type 2 and Sporadic Medullary Thyroid Carcinoma in Taiwan

  • Chin-Feng Chang

      Affiliations

    • Department of Laboratory Medicine, National Taiwan University Hospital;, Taipei, Taiwan
    • Department of Genetic Counseling Program, Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Wei-Shiung Yang

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital;, Taipei, Taiwan
    • Department of Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Genetic Counseling Program, Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Yi-Ning Su

      Affiliations

    • Department of Medical Genetics, National Taiwan University Hospital;, Taipei, Taiwan
    • Department of Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan
    • Department of Genetic Counseling Program, Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • I-Ling Wu

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital;, Taipei, Taiwan
    • Department of Genetic Counseling Program, Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
    • ,
  • Tien-Chun Chang

      Affiliations

    • Department of Internal Medicine, National Taiwan University Hospital;, Taipei, Taiwan
    • Department of Medicine, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Tien-Chun Chang, Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 16 May 2008 ,Revised 24 September 2008 ,Accepted 9 December 2008.

References 

  1. Bachelot A , Lombardo F , Baudin E , et al.   Inheritable forms of medullary thyroid carcinoma . Biochimie . 2002;84:61–66
  2. Kouvaraki MA , Shapiro SE , Perrier ND , et al.   RET protooncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors . Thyroid . 2005;15:531–544
  3. Massoll N , Mazzaferri EL . Diagnosis and management of medullary thyroid carcinoma . Clin Lab Med . 2004;24:49–83
  4. Leboulleux S , Baudin E , Travagli JP , et al.   Medullary thyroid carcinoma . Clin Endocrinol . 2004;61:299–310
  5. Carney JA . Familial multiple endocrine neoplasia: the first 100 years . Am J Surg Pathol . 2005;29:254–274
  6. Brandi ML , Gagel RF , Angeli A , et al.   Guidelines for diagnosis and therapy of MEN type 1 and type 2 . J Clin Endocrinol Meta . 2001;86:5658–5671
  7. Carling T . Multiple endocrine neoplasia syndrome: genetic basis for clinical management . Curr Opin Oncol . 2005;17:7–12
  8. Arighi E , Borrello MG , Sariola H . RET tyrosine kinase signaling in development and cancer . Cytokine Growth Factor Rev . 2005;16:441–467
  9. Santoro M , Melillo RM , Carlomagno F , et al.   Minireview: RET: normal and abnormal functions . Endocrinology . 2004;145:5448–5451
  10. Alberti L , Carniti C , Miranda C , et al.   RET and NTRK1 proto-oncogenes in human diseases . J Cell Physiol . 2003;195:168–186
  11. Machens A , Niccoli-Sire P , Hoegel J , et al.   Early malignant progression of hereditary medullary thyroid cancer . N Engl J Med . 2003;349:1517–1525
  12. Hansford JR , Mulligan LM . Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis . J Med Genet . 2000;37:817–827
  13. Ichihara M , Murakumo Y , Takahashi M . RET and neuroendocrine tumors . Cancer Lett . 2004;204:197–211
  14. Kodama Y , Asai N , Kawai K , et al.   The RET proto-oncogene: a molecular therapeutic target in thyroid cancer . Cancer Sci . 2005;96:143–148
  15. Jain S , Watson MA , DeBenedetti MK , et al.   Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors . Cancer Res . 2004;64:3907–3913
  16. Blank RD , Sklar CA , Dimich AB , et al.   Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds . Cancer . 1996;78:1996–2003
  17. Huang CN , Wu SL , Chang TC , et al.   RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma . J Formos Med Assoc . 1998;97:541–546
  18. Wu SL , Chang TC , Huang CN , et al.   Germline RET protooncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A . J Formos Med Assoc . 1998;97:614–618
  19. Chang TJ , Wu SL , Chang TC , et al.   De novo RET protooncogene mutation in a patient with multiple endocrine neoplasia type 2B . J Formos Med Assoc . 1999;98:692–697
  20. Erdogan MF , Gursoy A , Ozgen G , et al.   Ret proto-oncogene mutations in apparently sporadic Turkish medullary thyroid carcinoma patients: Turkmen study . J Endocrinol Invest . 2005;28:806–809
  21. Da Silva AM , Maciel RM , Da Silva MR , et al.   A novel germline point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma . J Clin Endocrinol Metab . 2003;88:5438–5443
  22. Komminoth P , Roth J , Muletta-Feurer S , et al.   RET protooncogene point mutations in sporadic neuroendocrine tumors . J Clin Endocrinol Metab . 1996;81:2041–2046
  23. Lee MJ , Su YN , You HL , et al.   Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1 . Hum Mutat . 2006;27:832
  24. Cote GJ , Gagel RF . Lessons learned from the management of a rare genetic cancer . N Engl J Med . 2003;349:1566–1568
  25. Skinner MA , Moley JA , Dilley WG , et al.   Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A . N Engl J Med . 2005;353:1105–1113
  26. Machens A , Ukkat J , Brauckhoff M , et al.   Advances in the management of hereditary medullary thyroid cancer . J Intern Med . 2005;257:50–59
  27. Moore SW , Appfelstaedt J , Zaahl MG . Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2 . J Pediatr Surg . 2007;42:326–332
  28. Wiench M , Wygoda Z , Gubala E , et al.   Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients . J Clin Oncol . 2001;19:1374–1380
  29. Lesueur F , Cebrian A , Robledo M , et al.   Polymorphisms in RET and its coreceptors and ligands as genetic modifiers of multiple endocrine neoplasia type 2A . Cancer Res . 2006;66:1177–1180
  30. Boikos SA , Stratakis CA . Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment . Histol Histopathol . 2008;23:109–116
  31. Zhou Y , Zhao Y , Cui B , et al.   RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B . Clin Endocrinol . 2007;67:570–576
  32. Kim IJ , Kang HC , Park JH , et al.   RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes . Clin Cancer Res . 2002;8:457–463
  33. Chung YJ , Kim HH , Kim HJ , et al.   RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A . Thyroid . 2004;14:813–818
  34. Bae SJ , Kim DJ , Kim JY , et al.   A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A . Thyroid . 2006;16:609–614
  35. Machens A , Dralle H . Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside . Mol Cell Endocrinol . 2006;247:34–40
  36. Machens A , Brauckhoff M , Holzhausen HJR , et al.   Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2 . J Clin Endocrinol Metab . 2005;90:3999–4003
  37. Yip L , Cote GJ , Shapiro SE , et al.   Multiple endocrine neoplasia type 2–evaluation of the genotype–phenotype relationship . Arch Surg . 2003;138:409–416
  38. van Heurn LWE , Schaap C , Sie G , et al.   Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children . J Pediatr Surg . 1999;34:568–571
  39. Huang SH , Kou MS , Jin YT , et al.   Prophylactic total thyroidectomy in an 8-year-old girl with multiple endocrine neoplasia type 2A . J Formos Med Assoc . 2001;100:274–276
  40. Uchino S , Noguchi S , Sato M , et al.   Presymptomatic detection and treatment of Japanese carriers of the multiple endocrine neoplasia type 2A gene . Surg Today . 1999;29:862–867
  41. Kameyama K , Takami H . Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002 . Endocr J . 2004;51:453–456
  42. Kameyama K , Okinaga H , Takami H . RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan . Biomed Pharmacother . 2004;58:345–347
  43. Huang SM , Tao BL , Tzeng CC , et al.   Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A . J Formos Med Assoc . 1997;96:542–544
  44. Martinelli P , Maruotti GM , Pasquali D , et al.   Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report . J Endocrinol Invest . 2004;27:357–360

PII: S0929-6646(09)60084-X

doi: 10.1016/S0929-6646(09)60084-X

Journal of the Formosan Medical Association
Volume 108, Issue 5 , Pages 402-408 , May 2009

Article Tools